Zepp Health Corporation
ZEPP
$2.81
$0.0752.75%
NYSE
| 09/30/2024 | 03/31/2024 | 12/31/2023 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 42.46M | 40.01M | 83.06M | 83.06M | 83.11M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 42.46M | 40.01M | 83.06M | 83.06M | 83.11M |
| Cost of Revenue | 25.22M | 25.29M | 54.21M | 54.21M | 54.94M |
| Gross Profit | 17.24M | 14.72M | 28.85M | 28.85M | 28.17M |
| SG&A Expenses | 18.92M | 17.17M | 17.03M | 17.03M | 16.43M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 55.00M | 55.85M | 82.32M | 82.32M | 81.73M |
| Operating Income | -12.54M | -15.84M | 739.00K | 739.00K | 1.38M |
| Income Before Tax | -13.26M | -14.66M | 1.62M | 1.62M | 332.00K |
| Income Tax Expenses | -- | 71.60K | 2.78M | 2.78M | 66.00K |
| Earnings from Continuing Operations | -13.26M | -14.73M | -1.15M | -1.15M | 266.00K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 8.00K | 32.20K | -14.80K | -14.80K | 27.00K |
| Net Income | -13.25M | -14.70M | -1.17M | -1.17M | 293.00K |
| EBIT | -12.54M | -15.84M | 739.00K | 739.00K | 1.38M |
| EBITDA | -10.60M | -13.95M | 2.62M | 2.62M | 3.39M |
| EPS Basic | -13.13 | -14.50 | -1.24 | -1.24 | 0.31 |
| Normalized Basic EPS | -0.52 | -0.64 | 0.10 | 0.10 | 0.02 |
| EPS Diluted | -13.13 | -14.62 | -1.24 | -1.24 | 0.26 |
| Normalized Diluted EPS | -0.52 | -0.64 | 0.10 | 0.10 | 0.02 |
| Average Basic Shares Outstanding | 16.15M | 16.22M | 15.10M | 15.10M | 15.20M |
| Average Diluted Shares Outstanding | 1.01M | 1.01M | 943.40K | 943.40K | 1.00M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |